During neurodegenerative processes, cascades of degeneration and subsequent regeneration are triggered. However, the molecular nature of the factors involved in the neurodegeneration of the CNS remains largely unknown. In this study, the variations of protein expression in the striatum of adult Sprague±Dawley rats following 6-hydroxydopamine lesions were investigated, in order to better understand the molecular events occurring in the denervated target tissue. The rat striatum, ipsilateral to the lesion was analysed by two-dimensional gel electrophoresis followed by matrix assisted laser desorption/ ionization-time of¯ight mass spectrometry. Seven proteins were up-regulated (188.1±750% compared to control) in response to the lesion: amyloid precursor-like protein 2 (APLP2), kininogen, glucokinase, tropomyosin a chain, type brain-1 and calpactin I light chain; whilst four proteins, neural epidermal growth factor-like 2, minichromosome maintenance 6, and thyroid hormone receptor b-2, were down-regulated (to between 36% and 59% of levels in sham-operated controls). Three proteins that did not match with available data in the SWISS-PROT protein database were also determined. Immunohistochemical analysis demonstrated colocalization of APLP2 and tyrosine hydroxylase in the nigral neurons. Moreover, reduction of APLP2-positive neurons in the substantia nigra pars compacta as well as the increases in the substantia nigra pars reticulata and in the striatum were observed. Furthermore, the conditioned medium of the Chinese hamster ovary cells over-expressing APLP2-751 (chondroitin sulphate-modi®ed), but not APLP2-763 (nonchondroitin sulphate-modi®ed), was able to increase the number of the tyrosine hydroxylase-positive neurons in fetal mesencephalic cultures. These results suggest that the expression of APLP2, a protein that has been thought to be associated with Alzheimer's disease, is up-regulated in the striatum following dopaminergic denervation. They also support the view that chondroitin sulphate-modi®ed APLP2 protein may play an important role in the dopaminergic nigrostriatal system.
Introduction
Parkinson's disease is one of the most common neurodegenerative diseases, with degeneration of dopaminergic (DA) neurons that project from the substantia nigra (SN) to the striatum being the primary pathogenic mechanism. This pathogenesis results in drastic changes in the SN as well as its target, the striatum, for example, it has been reported that striatal extract from patients with Parkinson's disease promotes the growth of DA neurons in fetal mesencephalic cultures (Carvey et al., 1993) , suggesting a trophic activity of the striatum on DA neurons. A similar activity has also been observed with the cerebrospinal¯uid (fractions > 10 kDa) from patients with Parkinson's disease (Yu et al., 1994) . Thus, neurodegeneration of midbrain DA neurons appears to have a signi®cant impact on the target tissue. It has been demonstrated that expression of a number of factors which are known to stimulate the growth of central neurons in vitro, have been up-regulated in the DA denervated striatum. These include the neurotrophins brain-derived neurotrophic factor (BDNF) and members of glial cell line-derived neurotrophic factor (GDNF) family (Zhou et al., 2000) . It has also been found that DA denervation results in elevated expression of preproenkephalin, cannabinoid CB1 receptors and trkB receptors (Zhu et al., 1993; Numan & Seroogy, 1997; Romero et al., 2000) . Hydroxyl radical formation and DNA base alterations have also been observed in the DA-depleted striatum (Ferger et al., 2001) , thus, increased synthesis of trophic factors in the target region after denervation is only part of the of brain's response to injury. A complicated process appears to occur in the striatum following denervation, hence understanding the molecular changes in the striatum of a rat model of Parkinson's disease is an important step in unraveling the pathogenesis of Parkinson's disease and in developing novel approaches to repairing injured or diseased brain.
Apart from Parkinson's disease, Alzheimer's disease (AD) is also one of the most common neurodegenerative diseases. Deposition of beta-amyloid (Ab) in senile plaques is a major pathological characteristic of AD. Beta-amyloid is generated by proteolytic processing of amyloid precursor proteins (APP) (Goedert et al., 1991; Selkoe, 1994) . APP is a member of a family of proteins that includes the amyloid precursor-like proteins APLP1 and APLP2 (Kang et al., 1987; Wasco et al., 1992; Wasco et al., 1993) . APLP2 has the greatest homology to APP (52% identical) at the amino acid level, compared with APLP1, which is only 42% identical. APLP2 shows conservation of all 12 cysteine residues in the N-terminus, the Kunitz-protease inhibitor (KPI) domain, the putative zinc-, copperand heparin-binding domains, the putative mitogenic RERMS domain, and the cytoplasmic clathrin/talin-binding domain (Tanzi et al., 1988; Wasco et al., 1992; Slunt et al., 1994) . APLP2 isoforms are encoded by two alternatively spliced APLP2 transcripts. The APLP2-751 isoform is modi®ed by the addition of chondroitin sulphate glycosaminoglycan (CS GAG) at Ser-614 (Thinakaran & Sisodia, 1994) . Insertion of 12 amino acids immediately N-terminal to Ser-614 (i.e. APLP2-763 isoform) disrupts a consensus sequence required for the addition of a CS chain (Thinakaran & Sisodia, 1994; Shioi et al., 1995; Thinakaran et al., 1995b) . The CS GAG modi®cation of APLP2 occurs in a region with little homologuey to APP. This suggest that CS GAG modi®cation of a subset of APLP2 isoforms represents a means of generating functional diversity for these polypeptides (Thinakaran & Sisodia, 1994; Thinakaran et al., 1995b) .
APLP2 is widely present in mammalian tissues and including brain and cerebrospinal¯uid (Webster et al., 1995; Sisodia et al., 1996) , although its physiological function largely remains to be determined. APLP2 has been thought to play an important role in axonal path®nding and/or synaptogenesis in the olfactory bulb in adult life (Thinakaran et al., 1995a) . Further study has, however, demonstrated that no impaired axonal outgrowth of olfactory sensory neurons following bulbectomy in APLP2 knockout mice, arguing against an important role for APLP2 alone in this process (von Koch et al., 1997) . In APLP2/APP double knockout mice,~80% of the mice die within the ®rst week after birth, suggesting that APLP2 and APP are required for early postnatal development (von Koch et al., 1997) . In AD brain, APLP-2 immunoreactivity is observed in a subset of neuritic plaques. It is particularly conspicuous in large dystrophic neurites that also label with antibodies speci®c for APP and chromogranin A. This suggests that APLP2 may play a role in neuronal sprouting or pathogenesis in AD (Crain et al., 1996) . However, there is currently a lack of data showing the change of APLP2 in the DA nigrostriatal pathway following 6-hydroxydopanmine (6-OHDA) lesion.
In this study the protein repertoires (proteomes) of the striatum were compared in control animals and in animals which had received a unilateral 6-OHDA lesion of the nigrostriatal pathway. It was observed that there was an alteration in the expression of a total of 11 proteins, including APLP2, in the denervated striatum of the lesioned animals. It was also shown that the conditioned media (CM) of cells expressing-APLP2 variants may be able to promote the survival of DA neurons in culture.
Materials and methods

Placement of 6-OHDA-inducd lesions
All animal experiments were carried out in accordance with the NIH guidelines. Female, Sprague±Dawley rats weighing 180±220 g obtained from an animal house (Shanghai Institute of Physiology, Chinese Academy of Science) were anaesthetized with ketamine and xylazine. Unilateral DA degeneration of the striatum was achieved by stereotaxic injections of 6-OHDA into the ascending medial forebrain bundle as described previously (Ungerstedt & Arbuthnott, 1970) . Brie¯y, 4 mL of 6-OHDA (2 mg/mL in 0.2 mg/mL ascorbate-saline) was injected at 4.4 mm caudal to bregma, 1.2 mm lateral to midline, 7.8 mm below dura. Sham-lesioned animals received 4 mL of the ascorbate vehicle. The lesion parameters used in the present study resulted in the selective destruction of virtually all dopaminergic neurons in the SN (> 95%) and the ventral tegmental area (> 80%), as was indicated by reduction in mRNA levels of tyrosine hydroxylase (TH) (Zhu et al., 1993) , DA content and TH immunoreactivity (Zhou et al., 1996) . Two weeks after lesioning, rotational behaviour was assessed with apomorphine (0.05 mg/kg). The animals that exhibited adequate turning (i.e. at least six full body turns per minute for rats and three full body turns per minute for mice contralateral to the lesion side) were used for further study.
The brains were removed at 2, 4 or 6 weeks following surgery and the striata ipsilateral to the lesion side were then dissected out and stored at ±70°C until use.
Sample preparation
The striatal tissue was weighed and homogenized for 10 min in icecold lysis buffer consisting of 2.59 g urea, 1 mL 20% NP-40, 0.3 mL 40% Ampholine (pH 3.5±9.5, Amersham Pharmacia Biotechnology, Uppsala, Sweden), 1.35 mL H 2 O, 0.5 mL 1.0 M dithiothreitol (DTT). The homogenates were then centrifuged at 20 000 g for 1.5 h at 4°C, the supernatant collected and stored at ±70°C. Total protein concentration of the samples was determined using the Bradford method (Bradford, 1976) .
Two-dimensional electrophoresis
Two-dimensional electrophoresis was carried out using O'Farrel's method (O'Farrell, 1975) . Brie¯y, gel mixture for the ®rst dimension containing 6.19 g urea, 2.48 mL H 2 O, 1.5 mL 31.8% acrylamide (Boehringer Mannheim, Indpls., USA), 0.56 mL 40% Ampholine (pH range 3.5±9.5) and 2.25 mL 10% NP-40 with 40 mL of ammonia persulphate and 6 mL of N,N,N¢,N¢-tetramethylethylenediamine (TEMED, Promega, USA) with ingredients being added to the mixture prior to pouring into glass tubes (2 mm diameter, 18 cm height). After the gel polymerized, the glass tubes were set in the isoelectronic focusing apparatus (LiuYi, Beijing, China). The upper chamber was ®lled with 0.2 M NaOH and the lower chamber with 0.3 M phosphoric acid and the samples, 100 mg protein each, were applied to the gels. Electrophoresis was run at a voltage gradually ascending from 100 to 800 V in 4 h and then at 800 V constantly for 24 h. After electrophoresis, the ®rst dimension gels were incubated for 15 min at room temperature in equilibrium buffer (0.123 M Tris, 10% glycerol, 2% sodium dodecyl sulphate (SDS), 7 mM DTT) and then transfered to the top of the second dimensional SDS polyacrylamide gel. The second dimension electrophoresis was run at 150 V in a Protean XI Cell (Bio-Rad, USA).
The pI and molecular weight of the proteins were determined by comparison with pI markers (pI 3.6, 4.6, 5.4, 6.8, 7.2, 9. 3) or molecular mass markers ranging from 5 to 97 kDa respectively, (Amersham Pharmacia Biotechnology, Uppsala, Sweden).
Following the second dimensional electrophoresis, silver staining was carried out according to the procedure previously described by Yu et al. (2000) . Brie¯y, the gels were immersed in a ®xative containing 30% ethanol and 10% acetic acid for 20 min. They were then twice rinsed in water for 20 min followed by sensitization in 20% glutaraldehyde. After rinsing, the gels were soaked in 0.8% ammoniacal silver nitrate for 30 min. Silver staining was developed Proteomic analysis of denervated striatum 897 by incubation with solution consisting of 0.005% citric acid and 0.037% formaldehyde and was stopped by adding acetic acid. The silver-stained gel was scanned using an ArtixScan 1010 scanner, (Microtek, Taiwan) at high resolution, followed by analysis using 2D ImageMaster Elite software (Amersham Pharmacia Biotechnology, Uppsala, Sweden). Protein spots in the gel were quanti®ed in terms of their relative volume after background subtraction.
Protein identi®cation
Destain
Protein destaining and in-gel digestion were performed as described previously (Gharahdaghi et al., 1999) with minor modi®cations. Brie¯y, the spots were excised, destained with 30 mM K 3 Fe(CN) 6 in 0.1 M NaS 2 O 3 (1 : 1). The gels were cut into small pieces, rinsed with 200 mM NH 4 HCO 3 , dehydrated with acetonitrile (ACN) and were dried in a Speedvac evaporator.
In gel reduction, methylation and digestion
The dried gel pieces were incubated in a solution consisting of 100 mM NH 4 HCO 3 and 10 mM DTT at 37°C for 1 h, followed by incubation with 100 mM NH 4 HCO 3 containing 55 mM iodoacetamide for 30 min, the gel pieces were then rinsed with 100 mM NH 4 HCO 3 , dehydrated with ACN and dried.
The gels were immersed in 10 mL of mixture containing 0.1 g/L tosylphenylalanine chloromethylketone (TPCK)-trypsin, 50 mM NH 4 HCO 3 , 5 mM CaCl 2 , followed by incubation in the same mixture without trypsin overnight at 37°C. After this enzymatic digestion, the resultant peptides were extracted twice with 50 mL 5% TFA in 50% ACN. The extracted peptide solution was blended, dried, and dissolved in 20 mL 0.1% TFA.
Matrix assisted laser desorption/ionization-time of¯ight-mass spectrometry (MALDI-TOF MS) and peptide masses search
The samples in 20 mL 0.1% TFA were desalted in a pipette tip containing a small C18 microcolumn (Millipore, USA) and were then mixed with 5 mL a-cyano-4-hydroxycinnamic acid (CHCA) dissolved in 50% ACN : 0.1% TFA (1 : 1 v/v). The mixture was used for MALDI-Peptide mass ®ngerprint analyses which were performed on a ProFlex TM. III MALDI-TOF (Bruker, USA). Calibration was internal to the samples. Peptide masses obtained by MALDI-TOF were used to search the SWISS-PROT protein database with the peptidident tool on EXPASY (http://expasy.cbr.nrc.ca).
Fluorescent double-labelling immunohistochemistry
Two weeks after the lesion, rats were terminally anaesthetized with barbiturate and transcardially perfused with 0.9% sodium chloride followed by cold 4% paraformaldehyde in 0.1 M phosphate buffer. Brains were removed and sectioned at a thickness of 30 mm. Primary antibodies used in this study were rabbit polyclonal antibodies against APLP2 (1 : 1000, a generous gift of Dr G Thinakaran). The antibody recognizes the antigen with a high degree of speci®city (Thinakaran et al., 1995a) and has been used in other studies (Guo et al., 1998; Li et al., 1999) . Brain sections were incubated with two primary antibodies simultaneously followed by incubation with goat anti-rabbit IgG conjugated with Texas-Red (1 : 500, Molecular Probes, USA) and goat anti-mouse IgG conjugated to FITC (1 : 150, Sigma, USA). Fluorescent labelled sections were visualized with a¯uorescence microscope (Olympus, Japan) equipped with a cool CCD camera (SPOT, Japan). The number of APLP2-positive cells in each brain section was counted manually in the digital photos (100 Q magni®cation). The raw counts of the cells were corrected according to the formula of Abercrombie (1946) .
RNA isolation and reverse transcriptase-polymerase chain reaction (RT-PCR)
The animals were killed at various time points after lesion and the brains were quickly removed. At each time point, four to ®ve 6-OHDA-lesioned animals were used. The ipislateral striata were dissected out and stored at ±70°C until use. The tissues were homogenized and total RNA was isolated using a TOTALLY RNA isolation kit (Ambion, USA). Single strand cDNA was synthesized from 1 mg total RNA in a volume of 20 mL containing 50 pmol random hexamers (Gibco, BRL, USA), 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 50 mM DTT, 0.75 U RNasin (Promega, USA), 0.2 mM each of dATP, dCTP, dGTP, and dTTP, and either 200 U or no MMLV reverse transcriptase (Life Technologies, UK). Reactions were incubated for 1 h at 37°C, terminated by heating 5 min at 95°C, and stored at ±70°C.
Oligonucleotide primers were designed to amplify the region (nt. 1201±1760) of APLP2:
forward, 5¢-GCCAACCAATGATGTGGACG-3¢ and backward, 5¢-CTTGAGCCACATAAGGCAC-3¢ Primers were also designed to amplify regions of coding sequence from the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene. Negative control templates for each set of PCR reactions included H 2 O to show that no contaminants were introduced during reaction preparation. Ampli®cation was performed with a thermal cycler (Mastercycler Gradientâ, Eppendorf, Germany) in a volume of 60 mL containing 3±5 mL template, 25 pmol each primer and 1.25 U Taq polymerase (Promega, USA) in 1 Q PCR buffer, 0.2 mM each of dATP, dGTP, dCTP and dTTP, 1.5 mM MgCl 2 . Cycle condition consisted of 5 min at 94°C followed by 1 min at 94°C, 1 min at 50°C, 2 min at 72°C for 3 cycles; 1 min at 94°C, 1 min at 53°C, 2 min at 72°C for 32 cycles ended with 72°C for 7 min. To conduct semiquantitative RT-PCR, the concentration of GAPDH cDNA of each sample was adjusted to same level before PCR ampli®cation. The ampli®cations were carried through 25, 30 or 35 cycles. The PCR products, 20 mL each, were subjected to 1.5% agarose gel electrophoresis, stained with ethidium bromide, visualized with a UV transilluminator, and photographed using a Kodak DC290 gel documentation system. The optical densities of ampli®ed bands at the end of 35 cycles, or 22 cycles for GAPDH, were measured using Scion Image analysis software (beta 4.02, Scion Corporation, Frederick, MD, USA) and expressed as a percentage of control (100%). All PCR products obtained were sequenced using automated PCR sequencer (ABI Prism System, Perkin-Elmer, USA) to con®rm their molecular identity.
Cell lines
The Chinese hamster ovary (CHO) cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM, Life Technologies, Inc., UK) supplemented with 10% fetal bovine serum (Life Technologies, Inc., UK), penicillin (100 units/mL), and streptomycin (100 mg/mL) (complete medium). The generation of stable CHO lines expressing APLP2-751 and APLP2-763 (generously provided by Dr F. S. Yu) were as described previously (Li et al., 1999) . Cells were maintained in complete DMEM containing 200 mg/mL geneticin.
To collect conditioned medium, the cells were rinsed with DMEM ®ve times followed by incubation with serum-free medium [DMEM/
Ham's F12 (1 : 1) supplemented with N2 (1 : 100, Gibco, Life Technologies, Inc., UK)] for 12 h.
In vitro DA neuron-survival assay Survival-promoting effects were assayed using the widely used procedure of Hyman et al (Hyman et al., 1991; Hyman et al., 1994) . In brief, fetal ventral mesencephalic tissue was obtained at day 14 of gestation (day 0 was day of vaginal plug). Following washing, the tissue was incubated in Hank's buffered saline solution containing 1 mg/mL trypsin and 0.5 mg/mL DNase at 37°C for 10 min. Tissue was then sequentially washed in HBSS containing DNase. The rat mesencephalic cells were seeded into 96-well plates (Nunc, Denmark) precoated with poly-L-lysine (10 mg/mL) (Zhou et al., 1994) . Cell viability in the suspensions of dissociated cells was determined by the ability of viable neurons to exclude the dye trypan blue. The cells were plated at 1 Q 10 5 cells/cm 2 in DMEM and The striatal proteins were extracted and separated on Ampholine (pH 3.5±9.5), followed by 5±20% SDS-polyacrylamide gels, as stated in Materials and methods Section. The gels were the silver-stained. Following identi®cation of differentially expressed proteins by analysis using the 2D ImageMaster Elite software, the stained proteins whose expression levels were either up-or down-regulated, were analysed by MALDI-TOF MS. The differentially expressed proteins were arbitrarily labelled with a number. The names of the proteins are listed in In the DA denervated striatum, 6-OHDA-lesion induced signi®cant changes in protein expression pattern. Pro®les of differentially expressed proteins in the striatum taken from 6-OHDA-lesioned rats at 2, 4 and 6 weeks postsurgery. The plots refer to the intensity of the marked spots in each sample. The abundance refers to the intensity values of the spots as they were quanti®ed in comparison with the total protein present in the gel. Values represent means T SEM, determined from ®ve lesioned and ®ve control rat brains. *P < 0.05 compared with sham control (two-way ANOVA followed by Dunnet test).
changed. Cells were incubated at 37°C in a 95% air/5% CO 2 humidi®ed atmosphere and maintained for 3 days following switching to the serum-free medium.
BrdU incorporation
The 6-OHDA-lesioned rats were given BrdU injections (50 mg/kg) every 2 h within 8 h at 1 week following surgery as described previously (Parent et al., 1997) . The rats were perfused with 4% paraformaldehyde 1 week after BrdU injection. The brains were removed and sectioned at 30 mm thickness and immunostained using an anti-BrdU monoclonal antibody (Sigma, St. Louis, USA). BrdU was visualized with metal concentrated DAB (Pierce, USA).
Statistical analysis
Statistical analysis was carried out using commercially available statistical software (GraphPad Prism v2.0, GraphPad Software Inc.). The data were subjected to either a one-way or a two-way analysis of variance (ANOVA) as indicated in the Results section. Either the Dunnet test or the Student±Newman±Keuls test (as a posthoc test) was used to compare data samples from the control group with the different treatment groups, or between pairs of groups. Differences were considered signi®cant only when P < 0.05.
Results
Differences in ipsilateral striatum between the 6-OHDAlesioned rats and sham controls
The striatal tissue extracts which were taken from the 6-OHDAlesioned rats 2 weeks following surgery were analysed by 2-D gel electrophoresis. Approximately 1400 spots were routinely observed in the silver-stained gels. Some protein spots migrated so closely that they could not always be resolved as individual spots and were therefore viewed as a group. The overall protein expression patterns in the gels were very similar between lesioned and control groups. The intensity of each protein spot on the gels of the denervated striatum was quanti®ed and compared to the corresponding control spot with the 2-D ImageMaster software. The relative levels of 11 proteins (mean of 5 gels for each sample) are given in Table 1 . Among these 11 spots, seven proteins were elevated and four reduced (Figs 1 and 2 ). The identities of these proteins were revealed by MALDI-TOF MS analysis following in-gel tryptic digestion. The ®ve up-regulated proteins were identi®ed as amyloid precursor-like protein 2 (APLP2, P15943), kininogen (P08934), glucokinase (GK, P17712), tropomyosin a chain, type brain-1 (TMBR-1, P18342) and calpactin I light chain (P05943) the other two up-regulated proteins did not match with any available protein data in the Swiss-Prot database in terms of their peptide pattern.
The lesion induced by 6-OHDA injection elicited a 5.35-fold increase in the level of APLP2 protein at 2 weeks post-lesion. This increase was sustained over 4±6 weeks. Likewise, the 6-OHDA lesion also induced signi®cant increases in expression of kininogen (2-fold), GK (1.88-fold), protein spots 3 (7.5-fold) and 5 (5.4-fold), TmBR-1 (3.1-fold) and calpactin I light chain (3.19-fold) at 2 weeks post-lesion. While the level of TMBR-1, similar to that of APLP2, remained elevated, the levels of the other proteins in 2 week-lesioned rats gradually decreased and had returned to control levels by 6 weeks post-lesion (Figs 1 and 2) .
The levels of neural epidermal growth factor-like 2 (NELL2, Q62918), thyroid hormone receptor b-2 (THRb-2, P37826), minichromosome maintenance (MCM) 6 (Q62724, a DNA replication licensing factor) and protein spot 11 were signi®cantly reduced by 40.5±64.0% at 2 weeks post-lesion. However, the levels of these proteins returned to control levels by 6 weeks post-lesion (Figs 1 and  2) , with the exception of NELL2 which remained down-regulated throughout all 6 weeks post-surgery.
Level of APLP2 mRNA increased in the striatum in response to the lesion.
To investigate whether mRNA levels of APLP2 and other proteins changed simultaneously with their protein levels, RT-PCR was employed. A faint band corresponding to APLP2 mRNA was observed in the striatum of the sham control throughout the time course, however, the band intensity was markedly increased at 2 weeks post-lesion and this increase persisted at 4 and 6 weeks postlesion (Fig. 3) .
Immunohistochemical analysis of APLP2 expression in the striatum and the SN following 6-OHDA lesion of nigrostriatal pathway
As shown in Fig. 1 and Table 1 , proteomatric analysis revealed a marked increase of APLP2 spot intensity in the DA denervated striatum. Consistent with the ®ndings from 2-D gel electrophoresis analysis, the 6-OHDA lesion resulted in an apparent increase in the number of APLP2-positive cells in the striatum ipsilateral to lesion FIG. 3 . Differential mRNA expression of APLP2 in the striatum ipsilateral to lesion following 6-OHDA infusion. The animals were killed at various time points after lesion and the brains were quickly removed. (A) Representative photos of ethidium bromide-stained PCR products ampli®ed with speci®c primer pairs of APLP2. Ampli®cations of GAPDH cDNAs were also performed. (B) Quantitative results of (A). The optical densities of ampli®ed bands were measured and the results expressed as a ratio of optical densities of ampli®ed bands versus GAPDH (mean T SEM, n = 3).
(control, 1619 T 379.6; denervated striatum, 3037.1 T 532, n = 2, Fig. 4A and B) . In the striatum, APLP2 immunoreactivity was largely distributed in the dorsal part of the head and it was not prominent in the other parts of the striatum. APLP2-positive neurons can also be seen in other brain regions, such as cerebrocortex, hippocampus and hypothalamus, suggesting an extensive involvement in brain function.
APLP2 immunoreactivity was also abundant in the substantia nigra pars compacta (SNc) and the ventral tegmental area in the contralateral side, but less abundant in the SN pars reticulata (SNr) (Fig. 4C) . These regions contain large groups of DA neurons (Fig. 4E) . Fluorescent double staining of APLP2 and TH revealed that many of the DA neurons expressed APLP2 (Fig. 4G) . However, TH-positive neurons were almost depleted in the ipsilateral SNc following 6-OHDA infusion (Fig. 4F ) and the number of APLP2-positive neurons was also signi®cantly reduced (number of APLP2-positive neurons: control, 1246 T 90.4; lesion-side, 312 T 50.1, n = 3). Conversely, the number of APLP2-positive neurons in the SNr was dramatically increased at 2 weeks postsurgery (control, 1134 T 380.9; lesion-side, 1955 T 507.5, n = 3; Fig. 4D ), suggesting role for APLP2 in the nigrostriatal system in the adult postinjury. No obvious alteration of APLP2 expression in other brain regions was observed.
6-OHDA lesion did not elicit detectable neurogenesis
To determine whether the increased number of APLP2-positive neurons is the result of neurogenesis in the striata following 6-OHDA lesion the lesioned rats received multiple injections of BrdU. The subsequent immunohistochemical analysis showed that no BrdUlabelled cells were found in either the striatum or SN at 2 weeks postlesion (data not shown), suggesting that there was no signi®cant cell turnover occurring in these regions.
The conditioned medium (CM) of CHO cells expressing CS-modi®ed APLP2 increased the survival of mesencephalic TH-positive cells in the cultures
To investigate whether APLP2 improves the survival of midbrain DA neurons, fetal ventral mesencephalic cultures were treated with the CM of either untransfected CHO cells or cells transfected with APLP2-763 or APLP2-751. It was observed that the number of THpositive neurons was increased up to 1.77-fold when the cultures were incubated with a percentage (between 20 and 100%) of the CM of CHO cells transfected with APLP2-751, compared with the CM of untransfected CHO cells (two-way ANOVA, P < 0.001, Fig. 5D ). The CM of CHO cells transfected with APLP2-763 however, did not have such an effect (Fig. 5D ). The effect of the CM of untransfected CHO cells showed no signi®cant difference as compared to untreated cultures.
These results suggest that modi®cation of APLP2 by addition of CS chains potentiates the effects of APLP2 core protein on the survival of cultured TH-positive neurons.
Since the APLP2-751 has structural/functional homology to the Kunitz-type serine protease inhibitors (KPI) (Tanzi et al., 1988; Wasco et al., 1993) , the survival-promoting effect of another serine protease inhibitor, leupeptin, was also examined. It was observed that the survival of TH-positive cells was increased up to 2.2-fold following addition of leupeptin (Fig. 5E ). These results indicated that APLP2-751 present in the CM may act as a serine protease inhibitor in promotion of the survival of DA neurons in cultures.
Discussion
Two-dimensional electrophoresis in combination with MALDI-TOF MS is a straightforward and potent approach to unravelling differences in the protein levels between healthy and diseased states of a given tissue or cell type. Using this technology, this present study demonstrated that unilateral lesion of the nigrostriatal pathway with 6-OHDA induced signi®cant changes in the expression of several proteins, including three potentially novel proteins, in rat striatum. The spatio-temporal characteristics of this expression may indicate that at least some of the proteins could be part of the cascades of degeneration and/or regeneration triggered following the 6-OHDAinduced lesion of the nigrostriatal pathway and that APLP2 may play import role in this process. ± Unidenti®ed ± ± 0.0420 T 0.0094 0.025 T 0.0033 59 ± ± *The intensities of the spots were quanti®ed in comparison with the total proteins present in the gel and the percentage of the volume of the spots representing the particular protein was determined. APLP2, amyloid precursor-like protein 2; THRb-2, thyroid hormone receptor b-2; I-lc, I light chain; TMBR-1, tropomyosin achain, type brain-1. The striata from 6-OHDA lesioned rats at 2 weeks postsurgery and sham controls were extracted and separated by 2-D gel electrophoresis as described in the Material and methods section. The proteins were identi®ed by MALDI-TOF-MS, following in-gel digestion with trypsin. MALDI-Peptide mass ®ngerprint analyses were performed on ProFlex TM. III MALDI-TOF (Bruker, USA). Calibration was internal to the samples. Peptide masses obtained by MALDI-TOF were used to search the SWISS-PROT protein database with the peptidident tool on EXPASY (http://expasy.cbr.nrc.ca). Quanti®cation of the expression levels was performed from the silver-stained gels, using the 2D ImageMaster software. Analytical data from the protein identi®cation, i.e. the matching and total peptides and the protein amino acid sequence coverage by the matching peptides are shown.
Both APP and APLP2 are ubiquitously expressed in mammalian tissues and a variety of physiological and pathological roles have been suggested for these two proteins (Selkoe, 1994; Rassoulzadegan et al., 1998; Selkoe, 1998; Bayer et al., 1999; Homayouni et al., 1999; Coulson et al., 2000; Dodart et al., 2000) , but many aspects are still poorly understood. Wallace et al. have reported that lesions disrupting cholinergic innervation elevate the synthesis of APP in the cerebral cortex. Similarly, disruption of cortical adrenergic and serotonergic innervation induces cortical APP expression (Wallace et al., 1993) . These ®ndings suggest that induction of APP is a response to the loss of functional innervation in the cortex. The results of the present study, showing up-regulated expression of APLP2 in the denervated striatum, indicate that striatal APLP2 expression can be induced by the loss of DA innervation.
In the present study, it was observed that the APLP2-positive DA neurons disappeared in the SNc following 6-OHDA lesion, indicating that APLP2 is present in presynaptic neurons in the substantia nigra. Furthermore, the increased number of APLP2-positive striatal neurons observed here suggests that the up-regulated expression of APLP2 is also in the postsynaptic neurons of the nigrostriatal system. These results imply a role for APLP2 in synaptogenesis or the reorganization of synapses in the striatum. It is not yet clear if the increase in the number of APLP2-expressing cells in the striatum and the SNr following lesion is the result of neurogenesis in local regions or if it is due to trans-differentiation of neurons in the SNr and striatum in response to injury. The former hypothesis is consistent with the view that APLP2 is involved in axonal path®nding and/or synaptogenesis in the olfactory bulb which is in a state of continual turnover in adult life (Thinakaran et al., 1995a) . However, the observations described here support the hypothesis that the increase in APLP2 is the result of neuronal trans-differentiation in the striatum following nigrostriatal lesion, since no proliferative cells, as assessed by BrdU labelling, were observed. Moreover, the ®nding of downregulation of NELL2 and DNA replication licensing factor MCM6 following lesion also supports this notion since the expression of these two proteins have been demonstrated to be associated with the growth of neural cells and DNA replication (Watanabe et al., 1996; Labib et al., 2000) . Nevertheless, since this lesion is known to create a microenvironment in target tissue that favours neuronal growth, it is likely that upregulated APLP2 is one of the components contributing to this microenvironment. The data from the in vitro DA neuron-survival assay in the present study supports this notion and is also in line with a recent report demonstrating the survival-and neurite outgrowthpromoting effects of APLP2 on chick sympathetic neurons .
How might APLP2 function in promoting neuronal growth? Like APP, APLP2 is encoded by alternatively spliced mRNAs. One of the spliced exons has structural/functional homology to the KPI (Tanzi et al., 1988; Wasco et al., 1993) and one controls the addition of chondroitin sulphate (CS) to the core protein (Thinakaran & Sisodia, 1994; Shioi et al., 1995; Thinakaran et al., 1995b) . Furthermore, the APP family of proteins are known to undergo proteolytic cleavage and release their ectodomains into the extracellular milieu. The KPI domain is known to inhibit certain serine proteases including plasmin which is involved in wound healing (Hayashi et al., 1991; van Nostrand et al., 1995) . Thus, released APLP2 derivatives and their incorporation into the extra-cellular matrix may inhibit matrix associated serine proteinase activity in injured tissues. Hence, lesion-induced APLP2 accumulation may provide a mechanism to balance proteinase activity during extra-cellular matrix remodeling. CS proteoglycans in the extra-cellular matrix of the CNS, including neurocan and phosphocan, are believed to modulate cell adhesion, axonal growth and guidance during neural development (Grumet et al., 1996; Bovolenta & Fernaud-Espinosa, 2000) . Thus, CS- FIG. 4 . Immuno¯uorescence staining for APLP2 (red) and TH (green). Two weeks post-lesion, brains of the lesioned animals were ®xed and sectioned followed by immuno¯uorescence staining. For¯uorescent double-labelling immunohistochemistry, brain sections were incubated simultaneously with rabbit anti-APLP2 (1 : 1000) and mouse anti-TH antibodies (1 : 2000) followed by incubation with goat anti-mouse IgG conjugated with FITC (1 : 150) and goat antirabbit IgG conjugated to Texas-Red (1 : 500). Some APLP2-positive cells were detected in the striatum of contralateral side of lesion (A).However, more APLP2-positive cells were seen in the denervated striatum (B).Many APLP2 and TH double-labelled neurons were observed in the substantia nigra pars compacta (SNc) as indicated in G with arrows. Lesion with 6-OHDA resulted in depletion of TH-and APLP2-positive neurons in the SNc (D, F and H) . Note the robust APLP2 staining in the substantia nigra pars reticulata (SNr) following lesion (D).A, C, E and G show the contralateral side of the lesion. Arrows in C and D de®ne the SNc. Scale bar, 75 mm. modi®ed APLP2 may play a similar role in regeneration of the nigrostriatal pathway. Further studies are needed to clarify if APLP2 is shedded in the denervated striatum and if these shedded molecules are functioning as a neural growth-associated substance, released in the denervated striatum to stimulate neuronal regeneration.
It was also observed that expression of APLP2 in the SNr of the side of lesion was signi®cantly increased (Fig. 4D) . One possible explanation is that high level of APLP2 in the SNr resulted from retrograde transportation of the protein from the ipsilateral striatum where APLP2 expression was already up-regulated, since one of the main targets of striatal projections is the SNr (Parent & Hazrati, 1995) . An alternative explanation is that the degeneration of DA neurons of the SNc in Parkinson's disease triggers a cascade of functional changes, which leads to a signi®cant re-arrangement of functional organization in the basal ganglia. The functional rearrangement includes hyperactivities of the SNr medial and globus pallidus (Blandini et al., 2000) . Thus, up-regulation of APLP2 in the SNr may re¯ect this change following lesioning of nigrostriatal pathway. Further study needs to address the question of neurotransmitter phenotypic identity of these APLP2-expressing neurons and their possible biological function in this setting.
One of signi®cantly increased proteins identi®ed in this study was kininogen. Expression of kininogen mRNAs has been demonstrated in glia and endothelial cells in all brain regions. It may function as a precursor protein for kinins and/or cysteine proteinase inhibitors during cerebral in¯ammation (Takano et al., 1999) . Coincidentally, it has recently been found in our separate studies (L. Xu, H. Guo, Y. Shen and J. Zhou) that expression of cysteine proteinase inhibitors, such as cystatin C, is increased in the striatum following 6-OHDA lesion and is able to effectively promote the survival of cultured mesencephalic DA neurons.
It has previously been shown using RT-PCR that there is upregulation of mRNA expression levels of BDNF and the GDNF family in striatum following unilateral 6-OHDA lesion of nigrostriatal pathway (Zhou et al., 2000) . However, careful examination of the gel revealed no spots or changes in the spots corresponding to the predicted molecular weights and pI values of these neurotrophic factors. It seems likely that the quantities of these factors present in the denervated striatum are too low to be detected by the techniques used in the present study. It is also possible that 2-D gel electrophoresis studies do not allow reliable resolution of proteins with molecular masses below~15 kDa and/or very basic proteins.
It was not possible to determine the nature of spots 3 (pI 4.56; mol. wt. 53.5 kDa), 5 (pI 4.46; mol. wt. 45.9 kDa) and 11 (pI 5.05; mol. wt. 28.5 kDa) in this study. It is possible that these spots represent novel genes, identi®cation and characterization of which may unravel some candidates for neurotrophic factors and/or molecules involved in the regeneration of the nigrostriatal pathway.
In summary, we investigated differences in the expression levels of proteins in both DA-depleted striatum and control. Some of the differentially expressed proteins, such as APLP2, found in the present study may be associated with the survival and differentiation of midbrain DA neurons. The data presented here supports a novel mechanism of action of APLP2 in its neurotrophic activity on DA neurons. Further study of the proteins differentially expressed in the lesioned striatum should allow a determination of how they are involved in the degeneration and/or repair of the injured nigrostriatal pathway.
